PBS delisting triggers govt intervention on diabetes drug
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
Tag: insulin
The GP who built his own ‘pancreas’ says new research vindicates his leap of faithÂ
A GP who taught dozens of his own patients with type 1 diabetes to build unapproved medical devices to manage their condition says a new…
DIY looping keeps patients in target glucose range for longer: study
Kiwi research has shown the use of DIY automated insulin delivery could help patients with type 1 diabetes stay in their target glucose range for…
A GP guide to ophthalmic complications of diabetes
Diabetes mellitus is globally endemic and is one of the leading causes of blindness in adults. Diabetes may cause macrovascular disease, microvascular complications, neuropathy and…
Low-carb diets in type 1 diabetes
Type 1 diabetes (T1D) is an endocrine disorder characterised by autoimmune destruction of pancreatic islet cells and an inability to produce insulin. The condition is…
‘Breakthrough’: Scientists regenerate insulin in a diabetic pancreas
A novel drug and stem cell combination may pave the way for new type 1 diabetes therapies.
GLP-1 receptor agonists in the treatment of T2DM
At least six oral and two injectable medication classes are available as therapeutic options in Australia.
Kicking T2DM into touch using low-carb medicine
With low-carb approaches becoming popular among people with diabetes and obesity, GPs need to be familiar with the evidence and practice of low-car…
GPs in dark over bodybuilders’ misuse of insulin: coroner
A Sydney GP told the court doctors needed more guidance on how to identify and manage patients who used performance enhancing drugs.
Deprescribing diabetes meds with a low-carb approach
GPs can offer carbohydrate restriction as an option for glycaemic control in patients with type 2 diabetes.
